PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,143,622 | +2.3% | 2,466,388 | +4.3% | 0.18% | -10.2% |
Q2 2023 | $14,799,867 | +44.5% | 2,364,196 | +10.1% | 0.20% | +38.7% |
Q1 2023 | $10,242,864 | +52.7% | 2,147,351 | +178.4% | 0.14% | +35.2% |
Q4 2022 | $6,709,953 | +290.9% | 771,259 | +167.5% | 0.10% | +452.6% |
Q3 2022 | $1,716,715 | +143.5% | 288,292 | +482.8% | 0.02% | +35.7% |
Q2 2022 | $705,000 | – | 49,468 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |